SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits

作者
Renny Abraham,Venkatesh Goura,Venkata Ramalingayya Grandhi,Jayaprakash Tadiparthi,Narender Ganuga,Rajesh Babu Medapati,Nageswara Rao Muddana,Veera Raghava Chowdary Palacharla,Gopinadh Bhyrapuneni,Kumar Bojja,Venkat Reddy Mekala,Maheswari Srirangavaram,Rajesh Kumar Badange,Veena Reballi,Vinod Goyal,Santosh Kumar Pandey,Pradeep Jayarajan,Ramakrishna V. S. Nirogi
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:16 (S5) 被引量:1
标识
DOI:10.1002/alz.039288
摘要

Abstract Background Muscarinic acetylcholine receptors (mAChRs) belong to family of G protein coupled receptors (GPCRs) which are widely expressed throughout the body. Muscarinic receptors have been implicated in the pathophysiology of various central nervous system disorders. M1 muscarinic receptor subtype plays a vital role in cognition, attention mechanisms and sensory processing. Discovery and development of selective M1 muscarinic ligands have been largely unsuccessful mainly due to high conservation of the orthosteric binding site among this receptor family. Thus, ligands that positively modulate the less conserved M1 muscarinic allosteric site may be advantageous over the orthosteric agonists Method SUVN‐I6107 is a lead compound from the M1 positive allosteric modulator (PAM) program. The effects of SUVN‐I6107 on the allosteric site of the M1 receptor was evaluated using the reporter gene assay. In addition, binding potential towards the orthosteric site across the muscarinic receptor subtypes was also studied. The pharmacokinetic properties of SUVN‐I6107 were studied both in rodent and non‐rodent species. The pro‐cognitive potential of SUVN‐I6107 was studied in diverse models of learning and memory. The safety of SUVN‐I6107 was assessed using in‐vitro and in‐vivo systems. Result SUVN‐I6107is a selective M1‐PAM with no agonistic activity across the muscarinic receptor subtypes. SUVN‐I6107 has good oral bioavailability in animal models. It also has excellent brain penetration with adequate protein free fraction. SUVN‐I6107 reversed the time induced memory deficit in the object recognition task. It also attenuated the scopolamine induced memory deficits in the object recognition as well as the contextual fear conditioning task. SUVN‐I6107 enhanced the cerebral blood flow in rats, potentiated the effects of donepezil, and promoted non‐amyloidogenic APP processing in rats. SUVN‐I6107 did not have the side effects associated with the stimulation of the cholinergic system. SUVN‐I6107was found to be safe in the cardiovascular safety assays and early stage animal toxicity studies. Conclusion SUVN‐I6107is a novel, selective and potent M1‐PAM,demonstrating efficacy in animal models and devoid of cholinergic side effects.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
斯文败类的应助被AY采纳,获得10
刚刚
在水一方的应助被研友_8QyXr8采纳,获得10
刚刚
房佳皓完成签到,获得积分10
刚刚
1秒前
逹月发布了新的文献求助30
1秒前
英俊的铭的应助被一笑半步巅采纳,获得10
1秒前
sjl发布了新的文献求助10
2秒前
在水一方的应助被完美犀牛采纳,获得10
2秒前
2秒前
2秒前
李卓辰发布了新的文献求助10
2秒前
camille发布了新的文献求助10
3秒前
xjygo完成签到,获得积分10
3秒前
Jun的应助被海大鱼采纳,获得20
3秒前
ini发布了新的文献求助10
3秒前
3秒前
CipherSage的应助被JZCT采纳,获得10
4秒前
4秒前
六六发布了新的文献求助10
4秒前
YPHCC发布了新的文献求助30
4秒前
庞飞发布了新的文献求助10
4秒前
六月完成签到,获得积分10
5秒前
笨笨石头的应助被轻松乐巧采纳,获得10
5秒前
orixero的应助被小刘接好运采纳,获得10
5秒前
5秒前
5秒前
亮倪力完成签到,获得积分10
5秒前
敢为天下先完成签到,获得积分10
6秒前
谨慎觅露完成签到,获得积分10
7秒前
秦124a发布了新的文献求助20
7秒前
NexusExplorer的应助被风格化橙采纳,获得10
7秒前
难过谷雪完成签到,获得积分10
7秒前
慕青的应助被风格化橙采纳,获得10
7秒前
香蕉觅云的应助被他山之鱼采纳,获得10
7秒前
7秒前
sjl完成签到,获得积分10
7秒前
7秒前
爆米花的应助被CJB采纳,获得10
8秒前
bodhi发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175853
求助须知:如何正确求助?哪些是违规求助? 9567457
关于积分的说明 21792632
捐赠科研通 7770447
什么是DOI,文献DOI怎么找? 3431918
关于科研通互助平台的介绍 2556276
邀请新用户注册赠送积分活动 2477418